The amino acid sequence corresponding to residues 107-116 of hen egg-white lysozyme (HEL) has been identified as containing an immunodominant T-cell epitope recognized in association with the I-Ed molecule. The immunodominance of this epitope in HEL-primed H-2d mice was demonstrated by analysis of the T-cell proliferative response induced by synthetic peptides covering almost the entire HEL sequence. All the T-cell hybridomas from H-2d mice analyzed recognize the HEL sequence 107-116 in association with the
(105-120)-peptide was found to be immunogenic in H-2d mice. Thus, a single semiconservative substitution drastically reduces binding capacity and abolishes immunogenicity, suggesting that a strict correlation exists between binding of a peptide to Ia molecules and its immunogenicity.
Unlike immunoglobulins, which recognize soluble, native protein antigens, the antigen receptor of T lymphocytes recognizes denatured or partially degraded antigens in association with a molecule encoded by the major histocompatibility complex (MHC) (1, 2) .
The finding that antigen and the MHC molecule are recognized by a single T-cell receptor (3) (4) (5) implies that the two components of the ligand may physically interact on the membrane of antigen-presenting cells (APCs) prior to T-cell recognition (4, 5) . Direct experimental support of this hypothesis was the demonstration by Babbitt et al. (6) that a synthetic peptide corresponding to amino acids 46-61 of hen egg-white lysozyme (HEL) has a measurable affinity for the I-Ak molecule (a murine class II, or Ia, MHC molecule) and is also recognized preferentially by T cells together with this molecule. In contrast, the I-Ad molecule neither binds HEL-(46-61)-peptide nor acts as a restriction element for T-cell responses to this peptide. This observation was confirmed and extended by Buus et al. (7) , who showed that the chicken ovalbumin-(323-339)-peptide, recognized in the context of I-Ad in T-cell activation, binds preferentially to I-Ad. Moreover, analysis of 12 immunodominant peptides recognized together with MHC molecules has demonstrated preferential binding to the restriction element for 11 of the peptides (8) . In all these experiments, a correlation was found between the capacity of a given peptide to inhibit the binding of antigen to Ia and the capacity of the same peptide to inhibit antigen presentation by accessory cells (9) , as previously suggested by the observation that related synthetic amino acid polymers (10, 11) or synthetic peptides of known sequence (12) (14) and purified by reverse-phase HPLC.
T-Cell Proliferation. Mice were immunized subcutaneously at the base of the tail and in the hind footpads with HEL (100 ,g per mouse, or the molar equivalent for peptides) emulsified in complete Freund's adjuvant (CFA) (Difco). T-cell proliferation was assayed by [3H]thymidine incorporation (15) .
T-Cell Hybridomas. T-cell hybridomas were established by poly(ethylene glycol)-induced fusion oflymph node cells with the T-cell lymphoma line BW5147. Lymph node cells were obtained from mice immunized with HEL/CFA and restimulated in vitro for 3 days with HEL (100 ,g/ml) before cell fusion. After fusion, cells were cultured in selective medium and growing hybrids were screened for reactivity to HEL by assaying HEL-and APC-dependent production of interleukin 2 (IL-2 Table 2 for sequences). The response to HEL-(105-120)-peptide accounts for about 30%o of the total anti-HEL proliferative response in H-2d mice. Since peptides HEL-(101-116) and HEL-(107-129) also induce T-cell proliferation, the putative epitope is included in HEL residues 107-116. All the hybridomas derived from H-2d mice that we have studied (five out of five from two different fusions) recognize the above HEL region.
The restriction element used by these T-cell hybridomas was determined by inhibition of IL-2 production by monoclonal anti-Ia antibodies. For The patterns of T-hybridoma activation, inhibition of antigen presentation, and inhibition of binding to I-Ed are summarized in Table 2 .
Responsiveness of H-2d Mice Correlates with Residues 113 and 114. Activation and competition data obtained with T-cell hybridomas that recognize HEL-(105-120)-peptide in the context of I-Ed molecules, as well as peptide binding to I-Ed molecules, indicate that residue 113 is involved in antigen-T-cell receptor interaction, whereas residue 114 primarily influences the interaction between antigen and Ia molecules. This observation predicts that immunization of H-2d mice with [Lys1l3]HEL-(105-120) would induce a response specific for the immunogen and that immunization with [His114]HEL-(105-120) would not prime for a T-cell response (18) . We found that immunization of H-2d mice with HEL-(105-120)-peptide induced a T-cell population that exhibited the same specificity as the HEL-specific, I-Ed-restricted T-cell hybridomas; this population responded to peptides (Fig. 3) . As An Arg--His substitution at position 114 profoundly decreases the binding of HEL-(105-120) to the I-Ed molecules and prevents T-cell activation. One possible interpretation of this finding is that the difference between the size and/or shape of these two residues is recognized by the MHC molecule. Alternatively, this substitution could have a profound effect on the possible conformations of the peptide and prohibit the conformation favorable for binding to MHC.
It is clear from the sequence of HEL-(105-120)-peptide (19) , and from the intermingled occurrence of residues involved in T-cell activation and in interaction with Ia molecules, that the determinant included in the sequence 107-116 does not conform with the amphipathic helix model of T-cell epitopes (19, 20) . It is perhaps more likely that this peptide, as has been postulated for ovalbumin-(323-339)-peptide, assumes an extended conformation after interaction with MHC molecules (21) . Two interesting properties of the HEL-(107-116)-peptide are its very high hydrophilicity (22) and the lack of the sequence "motif' common to some T-cell epitopes (23) , but it remains unclear whether or not these characteristics are relevant to the peptide antigenicity. Considering the great variability in the properties of peptides that can serve as T-cell epitopes, the backbone structure of peptides, rather than the side-chain groups of amino acids, may be involved in the binding to MHC molecules. If this were the case, certain arrangements of side-chain groups may not allow the conformation(s) of a peptide required for its binding to MHC molecules. Such a mechanism would account for the binding of a multitude of peptides to any given MHC molecules and, at the same time, for the appearance of some degree of specificity.
